Adenocarcinoma of Lung Stage IV Completed Phase 2 Trials for Poziotinib (DB12114)

Also known as: Adenocarcinoma Lung Stage IV / Lung adenocarcinoma stage IV / Stage IV Lung Adenocarcinoma / Lung adenocarcinoma metastatic / Adenocarcinoma of lung, stage IV

IndicationStatusPhase
DBCOND0062752 (Adenocarcinoma of Lung Stage IV)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02979821Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)Treatment